42191-48-0

Basic information

• Product Name: 2-(3,4-DIMETHOXY-PHENYL)-N-HYDROXY-ACETAMIDINE
• Synonyms: AKOS BC-1648;2-(3,4-DIMETHOXY-PHENYL)-N-HYDROXY-ACETAMIDINE;BENZENEETHANIMIDAMIDE,N-HYDROXY-3,4-DIMETHOXY-;(Z)-2-(3,4-dimethoxyphenyl)-N-hydroxyacetimidamide(WX192342)
• CAS NO: 42191-48-0
• Molecular Formula: C₁₀H₁₄N₂O₃
• Molecular Weight: 210.23
• Product Categories: pharmacetical
• Mol File: 42191-48-0.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 396.375 °C at 760 mmHg
• Flash Point: 193.521 °C
• Appearance: /
• Density: 1.201 g/cm³
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-(3,4-DIMETHOXY-PHENYL)-N-HYDROXY-ACETAMIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(3,4-DIMETHOXY-PHENYL)-N-HYDROXY-ACETAMIDINE(42191-48-0)
• EPA Substance Registry System: 2-(3,4-DIMETHOXY-PHENYL)-N-HYDROXY-ACETAMIDINE(42191-48-0)

Safety Data

• Hazardous Substances Data: 42191-48-0(Hazardous Substances Data)

Usage

General Description

2-(3,4-Dimethoxy-phenyl)-N-hydroxy-acetamidine is a chemical compound with a molecular formula C11H14N2O3. It is a derivative of acetamidine and consists of a hydroxyl group attached to the nitrogen atom and a 3,4-dimethoxyphenyl group attached to the carbon atom. This chemical is known for its potential pharmacological properties, particularly as a potential drug candidate for the treatment of various diseases. It may also have applications in organic synthesis and chemical research. Additionally, 2-(3,4-Dimethoxy-phenyl)-N-hydroxy-acetamidine may serve as a valuable starting material for the development of new chemical entities with therapeutic relevance. Further research and studies are warranted to explore its potential uses and applications.

Upstream product

• 93-17-4 3,4-dimethoxyphenylacetonitrile 

Downstream Products

• 757878-04-9 2-(3,4-dimethoxy-phenyl)-acetamidine 
• 1235444-12-8 N'-(3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-ylcarbonyloxy)-(3,4-dimethoxyphenyl)acetimidamide 

Relevant articles and documents

NOVEL COMPOUNDS AND THEIR USE IN THERAPY

The invention provides compounds which inhibit N-myristoyltransferase and are selective for protozoal N-myristoyltransferase and, consequently suitable to treat microbial infections, including viral and fungal infections, and protozoan infections such as malaria, leishmaniasis and sleeping sickness.

New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same

A compound effective in the treatment of diabetic angiopathy, i.e. a selective β-receptor blocker has the formula STR1 wherein: R2 is a hydrogen or alkyl having one to five carbon atoms, R3 is alkyl having one to five carbon atoms, cycloalkyl or phenyl optionally substituted with hydroxyl or phenyl, or R2 and R3 together form a five- to eight-membered ring optionally containing also other heteroatoms and/or fused with an other ring, preferably phenyl, naphthyl, quinolyl, isoquinolyl, pyridyl, pyrazolyl, R5 is hydrogen or alkyl having one to four carbon atoms, cycloalkyl or phenyl optionally substituted with halogen, alkoxy having one to four carbon atoms or alkyl having one to four carbon atoms, R6 is hydrogen, alkyl having one to four carbon atoms or phenyl, m=0, 1 or 2, and n=0, 1 or 2.